Systematic Review of the Effect of Glucosamine on Joint Health while Focused on the Evaluation of Claims for Health Functional Food

건강기능식품의 기능성을 중심으로 한 글루코사민의 관절건강 기능성에 대한 체계적 고찰

  • Kim, Joohee (Biofood Network Center, Ewha Womans University) ;
  • Kim, Ji Yeon (Dept. of Food Science and Technology, Seoul National University of Science and Technology) ;
  • Kwak, Jin Sook (Biofood CRO Co., Ltd.) ;
  • Paek, Ju Eun (Biofood CRO Co., Ltd.) ;
  • Jeong, Sewon (Biofood Network Center, Ewha Womans University) ;
  • Kwon, Oran (Biofood Network Center, Ewha Womans University)
  • 김주희 (이화여자대학교 바이오푸드네트워크) ;
  • 김지연 (서울과학기술대학교 식품공학과) ;
  • 곽진숙 (주식회사 바이오푸드씨알오) ;
  • 백주은 (주식회사 바이오푸드씨알오) ;
  • 정세원 (이화여자대학교 바이오푸드네트워크) ;
  • 권오란 (이화여자대학교 바이오푸드네트워크)
  • Received : 2013.07.10
  • Accepted : 2013.10.01
  • Published : 2014.02.28


Although the functional ingredient has been evaluated based on scientific evidence by the Ministry of Food and Drug Safety (MFDS), the levels of scientific evidence and consistency of the results might vary according to the emerging data. Therefore, a periodic re-evaluation may be needed in some functional ingredients. In this study, we re-evaluated the scientific evidence for the joint health of glucosamine as a functional ingredient in health functional food. Literature searches were conducted using Pubmed, Cochrane, KISS, and IBIDS databases with the search term of glucosamine in combination with osteoarthritis. The search was limited to human studies published in English, Korean and Japanese. Using the MFDS's evidence based evaluation system for scientific evaluation of health claims, 34 human studies were identified and reviewed in order to evaluate the strength of the evidence supporting the relation between glucosamine and joint health. Among the 34 studies, significant effects for joint health were reported in 28 studies, and their daily intake amount was 1.5 to 2 g. Eleven out of 34 studies were identified, excluding severe radiographic osteoarthritis, and ten from those eleven studies reported significant effects for joint health. Based on this systematic review, we concluded that there was possible evidence to support a relation between glucosamine intake and joint health.


Supported by : 식품의약품안전처


  1. Specific functional food glucosamine. Ministry of Food and Drug Safety, Korea. (accessed May 2013).
  2. Health Functional Food Code. 2004. Ministry of Food and Drug Safety, Korea.
  3. Park TS. 2006. Report on "Functionality Reevaluation for Fatigue Recovery, Bone Metabolism, Skin Beauty Improvement, and Body Weight Reduction of Health Functional Foods". Korea Food and Drug Administration. No. 06052-053. (accessed May 2013).
  4. Bae SC. 2009. Report on "Effect of glucosamine and chondroitin in osteoarthritis". National Evidence-based Healthcare Collaboration Agency. report_list.jsp?boardNo=GA (accessed May 2013).
  5. Food and Drug Administration. Guidance compliance regulatory information. GuidanceDocumentsRegulatoryInformation/LabelingNutriti on/ucm073332.htm (accessed May 2013).
  6. Codex Guidelines for use of nutrition and health claims. CAC/GL 23-1997, Rev. 1-2004.
  7. Korea Food and Drug Administration. Regulation for evaluation on efficacy of health functional food. www.foodnara. (accessed May 2013).
  8. Clegg, DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, Bradley JD, Bingham CO, Weisman MH, Jackson CG, Lane NE, Cush JJ, Moreland LW, Schumacher R, Oddis CV, Wolfe F, Molitor JA, Yocum DE, Schnitzer TJ, Furst DE, Sawitzke AD, Shi H, Brandt KD, Moskowitz RW, Williamns J. 2006. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med 354: 795-808.
  9. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyere O, Giacovelli G, Henrotin Y, Dacre JE, Gossett C. 2001. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357: 251-256.
  10. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G, Rovati LC. 2002. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162: 2113-2123.
  11. Frestedt JL, Walsh M, Kuskowski MA, Zenk JL. 2008. A natural mineral supplement provides relief from knee osteoarthritis symptoms: a randomized controlled pilot trial. Nutr J 7: 9.
  12. Giordano N, Fioravanti A, Papakostas P, Montella A, Giorgi G, Nuti R. 2009. The efficacy and tolerability of glucosamine sulfate in the treatment of knee osteoarthritis: A randomized, double-blind, placebo-controlled trial. Curr Ther Res 70: 185-196.
  13. Herrero-Beaumont G, Ivorra JA, Del Carmen Trabado M, Blanco FJ, Benito P, Martín-Mola E, Paulino J, Marenco JL, Porto A, Laffon A, Araújo D, Figueroa M, Branco J. 2007. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebocontrolled study using acetaminophen as a side comparator. Arthritis Rheum 56: 555-567.
  14. Houpt JB, McMillan R, Wein C, Paget-Dellio SD. 1999. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J Rheumatol 26: 2423-2430.
  15. Petersen SG, Saxne T, Heinegard D, Hansen M, Holm L, Koskinen S, Stordal C, Christensen H, Aagaard P, Kjaer M. 2010. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Osteoarthritis Cartilage 18: 34-40.
  16. Noack W, Fischer M, Forster KK, Rovatis LC, Setnikar I. 1994. Glucosamine sulfate in osteoarthritis of the knee. Osteoarthritis Cartilage 2: 51-59.
  17. Braham R, Dawson B, Goodman C. 2003. The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med 37: 45-49.
  18. Muller-Fassbender H, Bach GL, Haase W, Rovati LC, Setnikar I. 1994. Glucosamine sulfate compared to ibuprofen in osteoarthritis of the knee. Osteoarthritis Cartilage 2: 61-69.
  19. Lee DY, Moon HS, Cho KH, Cheon JE. 2001. Effect of glucosamine for knee osteoarthritis. J Korean Knee Soc 13: 130-136.
  20. Marti-Bonmati L, Sanz-Requena R, Rodrigo JL, Alberich- Bayarri A, Carot JM. 2009. Glucosamine sulfate effect on the degenerated patellar cartilage: preliminary findings by pharmacokinetic magnetic resonance modeling. Eur Radiol 19: 1512-1518.
  21. Qiu GX, Gao SN, Giacovelli G, Rovati L, Setnikar I. 1998. Efficacy and safety of glucosamine sulfate versus ibuprofen in patients with knee osteoarthritis. Arzneimittelforschung 48: 469-474.
  22. Lopes Vaz A. 1982. Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of osteoarthrosis of the knee in out-patients. Curr Med Res Opin 8: 145-149.
  23. Pujalte JM, Llavore EP, Ylescupidez F. 1980. Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis. Curr Med Res Opin 7: 110-114.
  24. Drovanti A, Bignamini AA, Rovati AL. 1980. Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo- controlled double-blind investigation. Clin Ther 3: 260-272.
  25. Usha PR, Naidu MUR. 2004. Randomised, double-blind, parallel, placebo-controlled study of oral glucosamine, methylsulfonylmethane and their combination in osteoarthritis. Clin Drug Investig 24: 353-363.
  26. Zenk JL, Helmer TR, Kuskowski MA. 2002. The effects of milk protein concentrate on symptoms of osteoarthritis in adults: an exploratory, randomized, double-blind, placebo- controlled trial. Curr Ther Res 63: 430-442.
  27. Wilkens P, Scheel IB, Grundnes O, Hellum C, Storheim K. 2010. Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial. JAMA 304: 45-52.
  28. McAlindon T, Formica M, Valley ML, Lehmer M, Kabbara K. 2004. Effectiveness of glucosamine for symptoms of knee osteoarthritis: results from an internet-based randomized double-blind controlled trial. Am J Med 117: 643-649.
  29. Cibere J, Kopec JA, Thorne A, Singer J, Canvin J, Ronvinson DB, Pope J, Hong P, Grant E, Esdaile JM. 2004. Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum 51: 738-745.
  30. Hughes R, Carr A. 2002. A randomized, double-blind, placebo- controlled trial of glucosamine sulphate as an analgesic in osteoarthritis of the knee. Rheumatology 41: 279-284.
  31. Rozendaal RM, Koes BW, Osch GJVM, Ultterlinden EJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JAN, Weinans H, Bierma-Zeinstra SMA. 2008. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann Intern Med 148: 268-277.
  32. Rindone JP, Hiller D, Collacott E, Nordhaugen H, Arriola G. 2000. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J Med 172: 91-94.
  33. Trc T, Bohmova J. 2010. Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs. glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA). Int Orthop 35: 341-348.
  34. Mehta K, Gala J, Bhasale S, Naik S, Modak M, Thakur H, Deo N, Miller MJS. 2007. Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]. BMC Complement Altern Med 7: 34.
  35. Wangroongsub Y, Tanavalee A, Wilairatana V, Ngarmukos S. 2010. Comparable clinical outcomes between glucosamine sulfate-potassium chloride and glucosamine sulfate sodium chloride in patients with mild and moderate knee osteoarthritis: a randomized, double-blind study. J Med Assoc Thai 93: 805-811.
  36. Kawasaki T, Kurosawa H, Ikeda H, Kim S, Owasa A, Takazawa U, Mubota M, Ishijima M. 2008. Additive effects of glucosamine or risedronate for the treatment of osteoarthritis of the knee combined with home exercise: a prospective randomized 18-month trial. J Bone Miner Metab 26: 279-287.
  37. Ng NT, Heesch KC, Brown WJ. 2010. Efficacy of a progressive walking program and glucosamine sulphate supplementation on osteoarthritic symptoms of the hip and knee: a feasibility trial. Arthritis Res Ther 12: R25.
  38. Haflah NH, Jaarin K, Abdullah S, Omar M. 2009. Palm vitamin E and glucosamine sulphate in the treatment of osteoarthritis of the knee. Saudi Med J 30: 1432-1438.
  39. Bennett AN, Crossley KM, Brucner PD, Hinman RS. 2007. Predictors of symptomatic response to glucosamine in knee osteoarthritis: an exploratory study. Br J Sports Med 41: 415-419.
  40. Tao QW, Xu Y, Jin DE, Yan XP. 2009. Clinical efficacy and safety of Gubitong Recipe in treating osteoarthritis of knee joint. Chin J Integr Med 15: 458-461.
  41. Yoshimura M, Sakamoto K, Tsuruta A, Yamamoto T, Ishida K, Yamaguchi H, Nagaoka I. 2009. Evaluation of the effect of glucosamine administration on biomarkers for cartilage and bone metabolism in soccer players. Int J Mol Med 24: 487-494.
  42. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE, Oddis CV, Wolfe F, Lisse J, Furst DE, Bingham CO, Reda DJ, Moskowitz RW, Williams JH, Celgg DO. 2010. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis 69: 1459-1464.
  43. Sawitzke AD, Shi H, Finco MF, Dunlop DD, Bingham CO, Harris CL, Singer NG, Bradley JD, Silver D, Jackson CG, Lane NE, Oddis CV, Wolfe F, Lisse J, Furst DE, Reda DJ, Moskowitz RW, Williams JH, Celgg DO. 2008. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: a report from the glucosamine/chondroitin arthritis intervention trial. Arthritis Rheum 58: 3183-3191.
  44. Christgau S, Henrotin Y, Tanko LB, Rovati LC, Collette J, Bruyere O, Deroisy R, Reginster JY. 2004. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate. Clin Exp Rheumatol 22: 36-42.
  45. Bruyere O, Honore A, Ethgen O, Rovatis LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JYL. 2003. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate. Osteoarthritis Cartilage 11: 1-5.
  46. Bruyere O, Pavelka K, Rovati LC, Gatterova J, Giacovelli G, Olejarova M, Deroisy R, Reginster JY. 2008. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage 16: 254-260.
  47. Pavelka K, Bruyere O, Rovati LC, Olejarova M, Giacovelli G, Reginster JY. 2003. Relief in mild-to-moderate pain is not a confounder in joint space narrowing assessment of full extension knee radiographs in recent osteoarthritis structure- modifying drug trials. Osteoarthritis Cartilage 11:730-737.
  48. Bruyere O, Pavelka K, Rovati LC, Deroisy R, Olejarova M, Gatterova J, Giacovelli G, Reginster JY. 2004. Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies. Menopause 11: 138-143.
  49. Rovati LC, Pavelka K, Giacovelli G, Reginster JY. 2006. Assessment of joint space narrowing with conventional standing antero-posterior radiographs: relief in mild-to-moderate pain is not a confounder in recent osteoarthritis structure- modifying drug trials. Osteoarthritis Cartilage 14: A14-A18.
  50. Cibere J, Thorne A, Kopec JA, Singer J, Canvin J, Robinson DB, Pope J, Hong P, Grant E, Lobanok T, Ionescu M, Poole AR, Esdaile JM. 2005. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. J Rheumatol 32: 896-902.
  51. Rozendaal RM, Uitterlinden EJ, van Osch GJ, Garling EH, Willemsen SP, Ginai AZ, Verhaar JA, Weinans H, Koes BW, Bierma-Zeinstra SM. 2009. Effect of glucosamine sulphate on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial. Osteoarthritis Cartilage 17: 427-432.
  52. Petersson IF, Boegård T, Saxne T, Silman AJ, Svensson B. 1997. Radiographic osteoarthritis of the knee classified by the Ahlbäck and Kellgren & Lawrence systems for the tibiofemoral joint in people aged 35-54 years with chronic knee pain. Ann Rheum Dis 56: 493-496.
  53. Henrotin H, Chevalier X, Herrero-Beaumont G, Mcalindon T, Mobasheri A, Pavelka K, Schon C, Weinans H, Biesalki H. 2013. Physiological effects of oral glucosamine on joint health: current status and consensus on future research priorities. BMC Rese Notes 6: 115.

Cited by

  1. Herring and chicken/pork meals lead to differences in plasma levels of TCA intermediates and arginine metabolites in overweight and obese men and women vol.61, pp.3, 2017,